Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Höffken

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Medical Microbiology and Immunology|November 30, 2002
Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatmentAdrian Gillissen, Gert Höffken
Medical Microbiology and Immunology|November 30, 2002
Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factorsGert Höffken, Adrian Gillissen
MMW Fortschritte Der Medizin|January 29, 2010
[Decision guidance for antibiotic treatment of acute exacerbation of COPD]Martin Kolditz, Gert Höffken
Chest|December 12, 2002
Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICUGert Höffken, Michael S Niederman
Critical Care Medicine|August 7, 2002
Adrenocortical function and inflammatory response during sepsisChristian Marx, Gert Höffken, Sirak Petros
The European Respiratory Journal|September 29, 2012
Management-based risk prediction in community-acquired pneumonia by scores and biomarkersMartin Kolditz, Santiago Ewig, Gert Höffken
Medizinische Klinik (Munich, Germany : 1983)|August 24, 2004
[Treatment of severe pneumonia--community-acquired and "early onset" nosocomial]Gert Höffken, Michael Halank, Adrian Gillissen
Treatments in Respiratory Medicine|August 10, 2005
Short-course antimicrobial therapy for community-acquired pneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Treatments in Respiratory Medicine|December 13, 2006
Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired PneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Respiratory Medicine|October 20, 2009
Acute effects of NPPV in interstitial lung disease with chronic hypercapnic respiratory failureDirk Koschel, Sabin Handzhiev, Bärbel Wiedemann, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Medical Microbiology and Immunology|November 30, 2002
Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatmentAdrian Gillissen, Gert Höffken
Medical Microbiology and Immunology|November 30, 2002
Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factorsGert Höffken, Adrian Gillissen
MMW Fortschritte Der Medizin|January 29, 2010
[Decision guidance for antibiotic treatment of acute exacerbation of COPD]Martin Kolditz, Gert Höffken
Chest|December 12, 2002
Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICUGert Höffken, Michael S Niederman
Critical Care Medicine|August 7, 2002
Adrenocortical function and inflammatory response during sepsisChristian Marx, Gert Höffken, Sirak Petros
The European Respiratory Journal|September 29, 2012
Management-based risk prediction in community-acquired pneumonia by scores and biomarkersMartin Kolditz, Santiago Ewig, Gert Höffken
Medizinische Klinik (Munich, Germany : 1983)|August 24, 2004
[Treatment of severe pneumonia--community-acquired and "early onset" nosocomial]Gert Höffken, Michael Halank, Adrian Gillissen
Treatments in Respiratory Medicine|August 10, 2005
Short-course antimicrobial therapy for community-acquired pneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Treatments in Respiratory Medicine|December 13, 2006
Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired PneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Respiratory Medicine|October 20, 2009
Acute effects of NPPV in interstitial lung disease with chronic hypercapnic respiratory failureDirk Koschel, Sabin Handzhiev, Bärbel Wiedemann, et al.
Pageof 3